Paris, ELCC 2025

April, 8 2025 - < 1 min read

From March 26 to 29, the European Lung Cancer Congress brought together international leaders in thoracic oncology, and we are proud to share that Dr. Arsela Prelaj, Principal Investigator of the I3LUNG Project, was one of the featured speakers and also served as chair of the session “The role of AI in lung cancer”, alongside Andreas Rimner.

In this educational session, Arsela presented her talk on the use of Artificial Intelligence in treatment response assessment, a key topic in advancing personalized and more effective medicine for lung cancer patients.

We also want to thank the other speakers of the session: Jakob Nikolas Kather (AI in lung cancer pathology), Florian J. Fintelmann MD (AI in lung cancer imaging), and Joseph (Joe) Deasy (AI in radiation treatment planning) for sharing their knowledge and expertise.

Stay tuned for more information and don’t forget to follow us on our social networks:

LinkedIn | Twitter | Instagram | Facebook

Share on: